Literature DB >> 23699915

Neurosteroids as therapeutic leads in psychiatry.

Charles F Zorumski1, Steven Mennerick.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23699915     DOI： 10.1001/jamapsychiatry.2013.245

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  7 in total

Review 1.  Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis.

Authors:  Vassilios Papadopoulos; Yasaman Aghazadeh; Jinjiang Fan; Enrico Campioli; Barry Zirkin; Andrew Midzak
Journal:  Mol Cell Endocrinol       Date:  2015-03-25       Impact factor: 4.102

2.  Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.

Authors:  Mingxing Qian; Kathiresan Krishnan; Eva Kudova; Ping Li; Brad D Manion; Amanda Taylor; George Elias; Gustav Akk; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2013-12-24       Impact factor: 7.446

3.  A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.

Authors:  E Sherwood Brown; John Park; Christine E Marx; Linda S Hynan; Claire Gardner; Domingo Davila; Alyson Nakamura; Prabha Sunderajan; Alexander Lo; Traci Holmes
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

4.  Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.

Authors:  P Wong; Y Sze; C C R Chang; J Lee; X Zhang
Journal:  Transl Psychiatry       Date:  2015-03-17       Impact factor: 6.222

Review 5.  Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Authors:  HuaLin Cai; Ting Cao; Xiang Zhou; Jeffrey K Yao
Journal:  Front Psychiatry       Date:  2018-03-08       Impact factor: 4.157

Review 6.  General Anesthesia and the Young Brain: The Importance of Novel Strategies with Alternate Mechanisms of Action.

Authors:  Stefan Maksimovic; Nemanja Useinovic; Nidia Quillinan; Douglas F Covey; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

7.  Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator.

Authors:  Alison L Althaus; Michael A Ackley; Gabriel M Belfort; Steven M Gee; Jing Dai; David P Nguyen; Tatiana M Kazdoba; Amit Modgil; Paul A Davies; Stephen J Moss; Francesco G Salituro; Ethan Hoffmann; Rebecca S Hammond; Albert J Robichaud; Michael C Quirk; James J Doherty
Journal:  Neuropharmacology       Date:  2020-09-22       Impact factor: 5.250
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.